Joyce O'Shaughnessy
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer (NCT03193853) | Joyce O'Shaughnessy | 2017-07-18 |
Track Joyce O'Shaughnessy automatically
Every clearance here is in the API, with alerts when new ones post.